论文部分内容阅读
目的:观察口服妇科内消胶囊联合CT引导下介入硬化治疗卵巢子宫内膜异位囊肿的临床疗效。方法:对42例患者在CT引导下经皮穿刺抽吸囊液并行无水乙醇硬化术后,随机分为2组;治疗组22例,术后加服妇科内消胶囊治疗;对照组20例术后服用安慰剂。所有患者术后随访6月,观察治疗前后2组病例囊肿大小变化、痛经改善情况及复发率。结果:术后6月,2组囊肿均明显缩小,与治疗前比较,差异均有非常显著性意义(P<0.01)。术后6月复发率治疗组为18.18%,对照组为50.00%,2组比较,差异有显著性意义(P<0.05)。治疗后2组痛经评分显著下降,与治疗前比较,差异均有非常显著性意义(P<0.01);治疗组下降较对照组更为显著(P<0.01)。结论:妇科内消胶囊配合介入治疗卵巢子宫内膜异位囊肿可有效控制复发率,能更好地改善痛经症状。
Objective: To observe the clinical efficacy of oral gynecological endocytic capsule combined with CT-guided interventional sclerosis in the treatment of ovarian endometriosis. Methods: Forty-two patients underwent CT-guided percutaneous aspiration of ascites and parallel alcoholic sclerosis. The patients were randomly divided into two groups: 22 in the treatment group and 20 in the control group Postoperative placebo. All patients were followed up for 6 months. Changes in cyst size, dysmenorrhea and recurrence were observed in 2 groups before and after treatment. Results: After 6 months, the cysts in both groups were significantly reduced, compared with before treatment, the difference was significant (P <0.01). The recurrence rate in June after operation was 18.18% in the treatment group and 50.00% in the control group. There was significant difference between the two groups (P <0.05). After treatment, the scores of dysmenorrhea decreased significantly in both groups, which were significantly different from those before treatment (P <0.01). The treatment group decreased more significantly than the control group (P <0.01). Conclusion: Gynecological Neixiao capsule with interventional treatment of ovarian endometriosis cysts can effectively control the recurrence rate, can better improve the symptoms of dysmenorrhea.